Capricor Therapeutics Inc (CAPR)

Date: O: H: L: C: Vol:

Finanzdaten der Capricor Therapeutics Inc-Aktie (CAPR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	16.79%42.95	36.77	29.16	26.28	27.72
Research and Development	5.44%28.87	27.38	23.13	20.36	22.05
Operating Income/Loss	16.79%-42.95	-36.77	-29.16	-26.28	-27.72
Nonoperating Income/Loss	21.82%2.21	2.83	-1.01	1.71	1.81
Income/Loss From Continuing Operations Before Tax	20.01%-40.73	-33.94	-	-24.57	-25.91
Income Tax Expense/Benefit	0.00	-	-	-	-
	20.01%-40.73	-33.94	-30.17	-24.57	-25.91
Attributable To Parent	20.01%-40.73	-33.94	-30.17	-24.57	-25.91
Basic Average Shares	0.86%57.93	57.43	-	45.72	45.71
Diluted Average Shares	0.86%57.93	57.43	-	45.72	45.71
Basic Earnings Per Share	18.64%-0.70	-0.59	-	-0.54	-0.57
Diluted Earnings Per Share	18.64%-0.70	-0.59	-	-0.54	-0.57